Dr. Mai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2022 - 2025
Johns Hopkins UniversityResidency, Internal Medicine, 2019 - 2022- Johns Hopkins University School of MedicineClass of 2019
Certifications & Licensure
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 11 citationsIsolated progression of metastatic lung cancer: Clinical outcomes associated with definitive radiotherapy.Cole Friedes, Nicholas Mai, Wei Fu, Chen Hu, Sarah Z. Hazell
Cancer. 2020-10-15 - 1 citationsPropensity score adjusted analysis of patients with isolated locoregional recurrence versus de novo locally advanced NSCLC treated with definitive therapy.Cole Friedes, Nicholas Mai, Wei Fu, Chen Hu, Peijin Han
Lung Cancer. 2020-07-01 - 9 citationsConsolidative Radiotherapy in Oligometastatic Lung Cancer: Patient Selection With a Prediction Nomogram.Cole Friedes, Nicholas Mai, Sarah Z. Hazell, Wei Fu, Peijin Han
Clinical Lung Cancer. 2020-05-23
Journal Articles
- Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancerNicholas Mai et al, NPJ Breast, 2024
- Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast CancerNicholas Mai et al, NPJ Breast, 2024
- Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancerNicholas Mai etal, NPJ Precision Oncology, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
